Besides urothelial cancer, previous studies also indicate there is a relationship between CTLA-4 -318 C/T polymorphism in cervical cancer [17-19,32], leukemia [21], melanoma [33], thymoma [34], lymphoma [20], skin cancer [35], and breast cancer [22]. This evidence concerns the gene CTLA4 and breast carcinoma.